Evidence map›Paper›PMID 33094383›Full record

SynthesisNeuroradiology2021

Radiological prognostic factors of chronic subdural hematoma recurrence: a systematic review and meta-analysis.

Ishita P Miah, Yeliz Tank, Frits R Rosendaal, Wilco C Peul, Ruben Dammers, Hester F Lingsma, Heleen M den Hertog, Korné Jellema, Niels A van der Gaag, Dutch Chronic Subdural Hematoma Research Group

Erratum issued 2 registry-linked trialsOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Neuroradiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05713630 phase3recruitingnot on this mapstarted 2026, after this paper: background citation

TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma

TypeinterventionalSponsorUnity Health TorontoRan2026 to 2030Enrolled130ConditionsSubdural HematomaArmsTranexamic acid (TXA), Placebo
NCT06466733 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)

TypeinterventionalSponsorJuan M. Ramos AcevedoRan2025 to 2032Enrolled658ConditionsChronic Subdural HematomaArmsEmbolization of the middle meningeal artery, Surgical Evacuation via burr hole or craniotomy
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Risk Factors of Chronic Subdural Hematoma Recurrence: A Systematic Review.Medical journal of the Islamic Republic of Iran · 2025
    Review
  19. Article
  20. Comparative clinical outcomes of irrigation techniques in burr-hole craniostomy for chronic subdural hemorrhage: a multicenter cohort study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ishita P MiahDepartment of Neurology and Neurosurgery, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. i.p.miah@lumc.nl.ORCID http://orcid.org/0000-0003-4676-7955
Yeliz TankDepartment of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Frits R RosendaalDepartment of Clinical Epidemiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Wilco C PeulDepartment of Neurology and Neurosurgery, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.
Ruben DammersDepartment of Neurosurgery, Erasmus Medical Center (EMC), Erasmus MC Stroke Center, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.
Hester F LingsmaDepartment of Public Health and Medical Decision Making, Erasmus Medical Center (EMC), Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.
Heleen M den HertogDepartment of Neurology, Isala Hospital Zwolle, Dokter van Heesweg 2, 8025, AB, Zwolle, The Netherlands.
Korné JellemaDepartment of Neurology and Neurosurgery, Haaglanden Medical Center (HMC), Lijnbaan 32, 2512, VA, The Hague, The Netherlands.
Niels A van der GaagDepartment of Neurology and Neurosurgery, Haaglanden Medical Center (HMC), Lijnbaan 32, 2512, VA, The Hague, The Netherlands.
Dutch Chronic Subdural Hematoma Research Group
Leiden University Medical Center · NLMedisch Centrum Haaglanden · NLErasmus MC · NLErasmus University Rotterdam · NLIsala · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChronic subdural hematoma (CSDH) is associated with high recurrence rates. Radiographic prognostic factors may identify patients who are prone for recurrence and who might benefit further optimization of therapy. In this meta-analysis, we systematically evaluated pre-operative radiological prognostic factors of recurrence after surgery.

methodsElectronic databases were searched until September 2020 for relevant publications. Studies reporting on CSDH recurrence in symptomatic CSDH patients with only surgical treatment were included. Random or fixed effects meta-analysis was used depending on statistical heterogeneity.

resultsTwenty-two studies were identified with a total of 5566 patients (mean age 69 years) with recurrence occurring in 801 patients (14.4%). Hyperdense components (hyperdense homogeneous and mixed density) were the strongest prognostic factor of recurrence (pooled RR 2.83, 95% CI 1.69-4.73). Laminar and separated architecture types also revealed higher recurrence rates (RR 1.37, 95% CI 1.04-1.80 and RR 1.76 95% CI 1.38-2.16, respectively). Hematoma thickness and midline shift above predefined cut-off values (10 mm and 20 mm) were associated with an increased recurrence rate (RR 1.79, 95% CI 1.45-2.21 and RR 1.38, 95% CI 1.11-1.73, respectively). Bilateral CSDH was also associated with an increased recurrence risk (RR 1.34, 95% CI 0.98-1.84). LIMITATIONS: Limitations were no adjustments for confounders and variable data heterogeneity. Clinical factors could also be predictive of recurrence but are beyond the scope of this study.

conclusionsHyperdense hematoma components were the strongest prognostic factor of recurrence after surgery. Awareness of these findings allows for individual risk assessment and might prompt clinicians to tailor treatment measures.

Indexed as

Hematoma, Subdural, ChronicAgedHumansPrognosisRadiographyRecurrenceRisk AssessmentChronic subdural hematomaCSDHCTPredictorsRecurrence

Identifiers

PMID33094383
PMCPMC7803717
OpenAlexW3094588454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.